The 2026 American Academy of Dermatology Annual Meeting put early, individualized assessment of pediatric acne, acne in children and teens, in the spotlight. For parents of teens, the headline means timely evaluation matters, not that a new treatment arrived. According to Dermatology Times meeting recap, the meeting ran March 27-31, 2026, in Denver as a clinical forum. The pediatric focus was on how childhood disease differs from adult disease and why early diagnosis helps.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the AAD session spotlighted
- Why early assessment helps teens
- What current care already includes
- How parents can use the headline
What the AAD session spotlighted
According to the AAD via PR Newswire, reported by Morningstar program notice, the 2026 program highlighted pediatric acne and rosacea. Rady Children's Hospital dermatologist Dawn Eichenfield, MD, FAAD, PhD, was set to discuss how pediatric disease differs from adult disease.
The session centered on early diagnosis and individualized assessment. The AAD 2026 program notice presents it as education for clinicians, not a new study result or guideline change.
Why early assessment helps teens
According to the AAD via Newswise, in updated acne guidance, acne affects about 85% of adolescents. Teens and preteens are the main affected group, though acne can persist in adults, especially women. Pediatric acne does not always behave like adult acne.
Early review lets a clinician track severity, scarring risk, and response over time. MDedge, reporting guidance from Lawrence Eichenfield and American Acne and Rosacea Society guidelines, flags mid-childhood acne as different. Acne arising at ages 1-7 is uncommon and can signal higher risk for an endocrine disorder. Referral to pediatric endocrinology is needed when growth, blood pressure, or early sexual maturation is abnormal.
What current care already includes
The AAD via Newswise states its updated acne guidelines cover adults, adolescents, and children over age 9. They were published in the Journal of the American Academy of Dermatology. An MDedge summary of the Journal guidance lists strong recommendations for several core treatments.
These include topical benzoyl peroxide, topical retinoids, topical antibiotics and fixed-dose combinations, plus oral isotretinoin for severe disease. Topical means applied to the skin. A fixed-dose combination puts two active ingredients in one product to simplify daily use.
How parents can use the headline
Use the headline as a reason to seek timely clinician evaluation. Bring onset age, family history, prior products, and photos showing change over time.
For the visit, prepare three details: Ask the clinician whether the plan follows current AAD guidance for your child's age and severity. Schedule follow-up before leaving so response and irritation can be reviewed.
- When breakouts started and where they appear
- What washes, leave-ons, and prescriptions were tried
- Changes in growth, blood pressure history, or early puberty signs
You Might Also Like
- Early Pediatric Acne Assessment Highlighted at AAD 2026: Skin-Care Routine Questions for Parents of Teens With Acne
- Early Pediatric Acne Assessment Highlighted at AAD 2026: Diagnosis and Look-Alike Questions for Parents of Teens With Acne
- Individualized Pediatric Acne Care Discussed at AAD 2026: Diagnosis and Look-Alike Questions for Parents of Teens With Acne